|
Volumn 18, Issue 6, 2003, Pages 1059-1060
|
Reflections on the HEMO study: The American viewpoint
|
Author keywords
Dialysis dose; Haemodialysis; HEMO study; Membrane flux; Randomized controlled trials
|
Indexed keywords
BETA 2 MICROGLOBULIN;
UREA;
ARTICLE;
BETA 2 MICROGLOBULIN URINE LEVEL;
CLINICAL TRIAL;
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIALYSIS MEMBRANE;
DOSE RESPONSE;
FACTORIAL ANALYSIS;
HEMODIALYSIS;
HEMOFILTRATION;
HUMAN;
KIDNEY CLEARANCE;
KIDNEY FAILURE;
KIDNEY FUNCTION;
KINETICS;
MAJOR CLINICAL STUDY;
MEMBRANE PERMEABILITY;
METHODOLOGY;
MORTALITY;
MULTICENTER STUDY;
OUTCOMES RESEARCH;
PATIENT SELECTION;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL RATE;
WATER QUALITY;
HEMODIALYSIS SOLUTIONS;
HUMANS;
KIDNEY FAILURE, CHRONIC;
RANDOMIZED CONTROLLED TRIALS;
RENAL DIALYSIS;
|
EID: 0038684596
PISSN: 09310509
EISSN: None
Source Type: Journal
DOI: 10.1093/ndt/gfg163 Document Type: Article |
Times cited : (12)
|
References (0)
|